OR4C16

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, OR4C16 mutation is significantly associated with the RNA expression of many other genes, with 5 significant associations in total. SCLC shows the largest number of these associations.

The most reproducible OR4C16-associated genes across cancer lineages are CSH1, LALBA, and OR10H5. Each is linked with OR4C16 in more than 1 cancer types. Because this analysis shows association rather than direction, both OR4C16-to-partner and partner-to-OR4C16 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CSH1 grouped by OR4C16-low versus OR4C16-high in SCLC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR4C16→partner) and Y-score (partner→OR4C16) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SCLCCSH1 →+0.312+5.189<.001.00631
SCLCLALBA →+0.260+4.847<.001.00931
SCLCOR10H5 →+0.127+5.624<.001.00331
SCLCSPANXC →+0.303+5.189<.001.00631
SCLCGRXCR2 →+0.133+4.847<.001.00931
Each partner links to its Q-omics profile. Showing the 5 strongest of 5 associations by consensus.

CSH1 by OR4C16 expression — SCLC

Box plot of CSH1 in OR4C16-low vs OR4C16-high samples in SCLC.

Explore this box plot interactively →

Exploration